Fibromyxoid aSoft Tissue Tumor With PLAG1 Fusion-The First Case in an Adult Patient
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu kazuistiky, časopisecké články
Grantová podpora
Research Project of the Ministry of Health of Czech Republic No 00064203
PubMed
39576105
PubMed Central
PMC11583838
DOI
10.1002/gcc.70011
Knihovny.cz E-zdroje
- Klíčová slova
- H3‐3B, PLAG1, NGS, fibromyxoid soft tissue tumor, mesenchymal neoplasm, nodular fasciitis,
- MeSH
- DNA vazebné proteiny * genetika MeSH
- dospělí MeSH
- fibrom genetika patologie MeSH
- fúze genů MeSH
- fúzní onkogenní proteiny genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory měkkých tkání * genetika patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- DNA vazebné proteiny * MeSH
- fúzní onkogenní proteiny MeSH
- PLAG1 protein, human MeSH Prohlížeč
With the expanding possibilities of human genome research in recent years, the number of cases of soft tissue tumors that we are able to classify into the correct subgroups and to reveal their molecular profile is increasing. Among such tumors, we can also consider neoplasms that have a specific fusion of genes, in our case namely the pleomorphic adenoma gene 1 (PLAG1) and its partner. PLAG1 gene fusions were previously associated mainly with salivary gland pleomorphic adenomas, lipoblastomas, myoepithelial tumors, uterine epitheloid, myxoid leiomyosarcomas, and, recently, with PLAG1-rearranged fibromyxoid soft tissue tumors. To our knowledge, we report the first case of a soft tissue tumor with a PLAG1 fusion gene in an adult. In our case, we detected a new H3-3B::PLAG1 fusion in a soft tissue tumor, which originally appeared as nodular fasciitis.
Zobrazit více v PubMed
Hehir‐Kwa J. Y., Koudijs M. J., Verwiel E. T. P., et al., “Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing,” JCO Precision Oncology 6 (2022): e2000504. PubMed PMC
Van Dyck F., Declercq J., Braem C. V., and Van de Ven W. J., “PLAG1, the Prototype of the PLAG Gene Family: Versatility in Tumour Development (Review),” International Journal of Oncology 30, no. 4 (2007): 765–774. PubMed
Antonescu C. R., Zhang L., Shao S. Y., et al., “Frequent PLAG1 Gene Rearrangements in Skin and Soft Tissue Myoepithelioma With Ductal Differentiation,” Genes, Chromosomes and Cancer 52, no. 7 (2013): 675–682. PubMed PMC
Tomás‐Velázquez A., Surrey L. F., Miele E., et al., “Mesenchymal PLAG1 Tumor With PCMTD1‐PLAG1 Fusion in an Infant: A New Type of "Plagoma",” American Journal of Dermatopathology 44, no. 1 (2022): 54–57. PubMed
Logan S. J., Schieffer K. M., Conces M. R., et al., “Novel Morphologic Findings in PLAG1‐Rearranged Soft Tissue Tumors,” Genes, Chromosomes & Cancer 60, no. 8 (2021): 577–585. PubMed
Chung C. T., Antonescu C. R., Dickson B. C., et al., “Pediatric Fibromyxoid Soft Tissue Tumor With PLAG1 Fusion: A Novel Entity?,” Genes, Chromosomes & Cancer 60, no. 4 (2021): 263–271. PubMed PMC
Aström A. K., Voz M. L., Kas K., et al., “Conserved Mechanism of PLAG1 Activation in Salivary Gland Tumors With and Without Chromosome 8q12 Abnormalities: Identification of SII as a New Fusion Partner Gene,” Cancer Research 59, no. 4 (1999): 918–923. PubMed
Santisukwongchote S., Thorner P. S., Desudchit T., et al., “Pediatric Fibromyxoid Tumor With PLAG1 Fusion: An Emerging Entity With a Novel Intracranial Location,” Neuropathology 42, no. 4 (2022): 315–322. PubMed
Drlík Z., Pock L., Vacková M., and Drlík L., “Nodulární fasciitis,” Čes‐slovDerm 92, no. 3 (2017): 125–127.
Lazák J., Kalfeřt D., Krsková L., et al., “Nodulární fasciitida pravé tváře s průkazem MYH9‐USP6 fúzního genu,” Otorinolaryngologie a Foniatrie 69, no. 1 (2020): 40–44.
Yoshida H., Miyachi M., Ouchi K., et al., “Identification of COL3A1 and RAB2A as Novel Translocation Partner Genes of PLAG1 in Lipoblastoma,” Genes, Chromosomes & Cancer 53, no. 7 (2014): 606–611. PubMed
Krsková L., Němečková T., Balko J., Brož P., and Vícha A., “Novel ZEB2‐PLAG1 Fusion Gene Identified by RNA Sequencing in a Case of Lipoblastoma,” Pediatric Blood & Cancer 68, no. 3 (2021): e28691. PubMed
Afshari M. K., Fehr A., Nevado P. T., Andersson M. K., and Stenman G., “Activation of PLAG1 and HMGA2 by Gene Fusions Involving the Transcriptional Regulator Gene NFIB,” Genes, Chromosomes & Cancer 59, no. 11 (2020): 652–660. PubMed
Asahina M., Hayashi T., Takamochi K., et al., “Identification of CTNNB1‐PLAG1 Gene Rearrangement in a Patient With Pulmonary Pleomorphic Adenoma,” Virchows Archiv 477, no. 5 (2020): 739–742. PubMed
Pedeutour F., Deville A., Steyaert H., Ranchere‐Vince D., Ambrosetti D., and Sirvent N., “Rearrangement of HMGA2 in a Case of Infantile Lipoblastoma Without PLAG1 Alteration,” Pediatric Blood & Cancer 58, no. 5 (2012): 798–800. PubMed
Hibbard M. K., Kozakewich H. P., Dal Cin P., et al., “PLAG1 fusion oncogenes in lipoblastoma,” Cancer Research 60, no. 17 (2000): 4869–4872. PubMed
Panagopoulos I., Andersen K., Gorunova L., et al., “Recurrent 8q11‐13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors,” Cancer Genomics Proteomics 20, no. 2 (2023): 171–181. PubMed PMC
J. A. Arias‐Stella, 3rd , Benayed R., Oliva E., et al., “Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors,” American Journal of Surgical Pathology 43, no. 3 (2019): 382–388. PubMed PMC
Panagopoulos I., Gorunova L., Andersen K., et al., “ NDRG1‐ PLAG1 and TRPS1‐PLAG1 Fusion Genes in Chondroid Syringoma,” Cancer Genomics & Proteomics 17, no. 3 (2020): 237–248. PubMed PMC
Gao Q., Liang W. W., Foltz S. M., et al., “Driver Fusions and Their Implications in the Development and Treatment of Human Cancers,” Cell Reports 23, no. 1 (2018): 227–238.e3. PubMed PMC
Okonechnikov K., Imai‐Matsushima A., Paul L., Seitz A., Meyer T. F., and Garcia‐Alcalde F., “InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts From Deep RNA‐Sequencing Data,” PLoSOne 11, no. 12 (2016): 1–24. PubMed PMC
Hu X., Wang Q., Tang M., et al., “TumorFusions: An Integrative Resource for Cancer‐Associated Transcript Fusions,” Nucleic Acids Research 46, no. D1 (2018): D1144–D1149. PubMed PMC
Behjati S., Tarpey P. S., Presneau N., et al., “Distinct H3F3A and H3F3B Driver Mutations Define Chondroblastoma and Giant Cell Tumor of Bone,” Nature Genetics 45, no. 12 (2013): 1479–1482. PubMed PMC